Neuca takes over Exom
Clinscience, a subsidiary of Neuca, buys 100 % of shares of the Italian Exom Group. Effective September 28, 2021, Cliniscience will purchase 60 % of the shares for EUR 13.2 million, including a total of EUR 5 million in the seller’s net cash position. The remaining 40 % will be purchased by 2025, for a…